Evidence map›Paper›PMID 32293347›Full record

ArticleBMC cancer2020

Challenges in the cultural adaptation of the German Myeloma Patient Outcome Scale (MyPOS): an outcome measure to support routine symptom assessment in myeloma care.

Christina Gerlach, Katherine Taylor, Marion Ferner, Markus Munder, Martin Weber, Christina Ramsenthaler

Abstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Assessment tools for patient-reported outcomes in multiple myeloma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christina GerlachInterdisciplinary Palliative Care Unit, III Department of Medicine, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany. christina.gerlach@unimedizin-mainz.de.
Katherine TaylorInstitute of Medical Biometrics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.
Marion FernerInterdisciplinary Palliative Care Unit, III Department of Medicine, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.
Markus MunderIII Department of Medicine, Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.
Martin WeberInterdisciplinary Palliative Care Unit, III Department of Medicine, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.
Christina RamsenthalerDepartment of Palliative care, Policy and Rehabilitation, King's College London, Florence Nightingale School of Nursing and Midwifery, Cicely Saunders Institute, London, UK.

Funding

University Medical Center of the Johannes Gutenberg University of Mainz, Germany Intramural Research Funding
6 · The paper itself

Abstract

backgroundPatients with multiple myeloma report more problems with quality of life (QoL) than other haematological malignancies over the course of their incurable illness. The patient-centred Myeloma Patient Outcome Scale (MyPOS) was developed to assess and monitor symptoms and supportive care factors in routine care. Our aim was to translate and culturally adapt the outcome measure to the German context, and to explore its face and content validity.

methodsTranslation and cultural adaptation following established guidelines used an exploratory, sequential mixed method study design. Steps included: (1) forward translation to German; (2) backward translation to English; (3) expert review; (4) focus groups with the target population (patients, family members, healthcare professionals) to achieve conceptual equivalence; (5) cognitive interviews using Tourangeau's model with think-aloud technique to evaluate comprehension and acceptability; (6) final review. Results were analysed using thematic analysis.

resultsCultural and linguistic differences were noted between the German and English original version. The focus groups (n = 11) and cognitive interviews (n = 9) both highlighted the need for adapting individual items and their answer options to the German healthcare context. Greater individuality regarding need for information with the right to not be informed was elaborated by patients. While the comprehensive nature of the tool was appreciated, item wording regarding satisfaction with healthcare was deemed not appropriate in the German context. Before implementation into routine care, patients' concerns about keeping their MyPOS data confidential need to be addressed as a barrier, whereas the MyPOS itself was perceived as a facilitator/prompt for a patient-centred discussion of QoL issues.

conclusionWith adaptations to answer options and certain items, the German version of the MyPOS can help monitor symptoms and problems afflicting myeloma patients over the course of the disease trajectory. It can help promote a model of comprehensive supportive and patient-centred care for these patients.

Indexed as

Cultural CharacteristicsTranslatingAdultAgedFemaleFollow-Up StudiesHealth PersonnelHumansMaleMiddle AgedMultiple MyelomaOutcome Assessment, Health CarePsychometricsQuality of LifeReproducibility of ResultsSurveys and QuestionnairesCultural adaptationHaematological malignancyMultiple myelomaPatient-reported outcome measurementQuality of lifeSupportive care

Identifiers

PMID32293347
PMCPMC7092563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.